GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (FRA:BV3) » Definitions » Gross-Profit-to-Asset %

Bavarian Nordic AS (FRA:BV3) Gross-Profit-to-Asset % : 16.44% (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Bavarian Nordic AS Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Bavarian Nordic AS's annualized Gross Profit for the quarter that ended in Sep. 2024 was €310.9 Mil. Bavarian Nordic AS's average Total Assets over the quarter that ended in Sep. 2024 was €1,891.7 Mil. Therefore, Bavarian Nordic AS's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 16.44%.


Bavarian Nordic AS Gross-Profit-to-Asset % Historical Data

The historical data trend for Bavarian Nordic AS's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic AS Gross-Profit-to-Asset % Chart

Bavarian Nordic AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.09 8.33 5.47 13.90 34.39

Bavarian Nordic AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.27 46.55 7.58 20.64 16.44

Competitive Comparison of Bavarian Nordic AS's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Bavarian Nordic AS's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic AS's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic AS's Gross-Profit-to-Asset % falls into.



Bavarian Nordic AS Gross-Profit-to-Asset % Calculation

Bavarian Nordic AS's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=617.574/( (1665.599+1925.718)/ 2 )
=617.574/1795.6585
=34.39 %

Bavarian Nordic AS's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=310.936/( (1912.565+1870.772)/ 2 )
=310.936/1891.6685
=16.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Bavarian Nordic AS Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic AS's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic AS Business Description

Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

Bavarian Nordic AS Headlines

No Headlines